Health Canada’s OTC codeine ban is a Band-Aid solutionWe want to expand the scope of pharmacists to take the burden off physicians and ERs, but this ban is a move in the opposite direction Drug benefit plan managers and sponsors often overlook pharmacistsAt the 2017 drug benefits summit, Mark Rolnick of Shoppers Drug Mart suggested opportunities are being missed Pay incentives for doctors don't improve follow-up rates for patients discharged from hospital Pharmacists lobby Ontario to establish $75 consultation for opioid management If prescription rates remain consistent with the previous year, the program could cost upwards of $150 million Ontario to cover HIV prevention drug under public health plan The brand name Truvada costs about $1,000 a month but new products are hitting the market at a quarter of that cost Pharmacare could save Canada over $4 billion a year in drug costs A new report from the Parliamentary Budget Officer comes a year after a House of Commons Standing Committee asked for a cost estimate Health systems often discriminate against Indigenous patients: Philpott Tresiba (insulin degludec): third basal insulin analogue in Canada Glucose-lowering effect of ultralong-acting basal insulin lasts for more than 42 hours How to address the opioid crisis? Invest in 'social capital' Closed hospital could re-open to address bed shortage, Ontario health minister says First Previous 1085 1086 1087 1088 1089 Next Last
